Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis

BACKGROUND & AIMS: Adverse events (AEs) including reactivation of herpes zoster (HZ) and venous thromboembolism (VTE) have been reported from clinical trials of tofacitinib in ulcerative colitis (UC). We investigated the incidence rates of AEs in a real-world study of UC patients given tofacitin...

詳細記述

保存先:
書誌詳細
出版年:Clin Gastroenterol Hepatol
主要な著者: Deepak, Parakkal, Alayo, Quazim A., Khatiwada, Aava, Lin, Bixuan, Fenster, Marc, Dimopoulos, Christina, Bader, Geoffrey, Weisshof, Roni, Jacobs, Michael, Gutierrez, Alexandra, Ciorba, Matthew A., Christophi, George P., Patel, Anish, Hirten, Robert P, Colombel, Jean-Frederic, Rubin, David T., Ha, Christina, Beniwal-Patel, Poonam, Ungaro, Ryan C., Syal, Gaurav, Pekow, Joel, Cohen, Benjamin L., Yarur, Andres
フォーマット: Artigo
言語:Inglês
出版事項: 2020
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7779667/
https://ncbi.nlm.nih.gov/pubmed/32629130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2020.06.050
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料